Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease
Conclusions:
Lower Na balance was produced by add-on HCTZ to ARB treatment without an increase of intra-renal renin-angiotensin system activity, leading to restoration of nocturnal hypertension. A further study is needed to demonstrate that the reduction of UAGTV by additional diuretics to ARBs prevents the progression of nephropathy or cardiovascular events.
Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - Category: Biomedical Science Authors: Fuwa, D., Fukuda, M., Ogiyama, Y., Sato, R., Mizuno, M., Miura, T., Abe-Dohmae, S., Michikawa, M., Kobori, H., Ohte, N. Tags: Original Article Source Type: research
More News: Biomedical Science | Cardiology | Cardiovascular | Chronic Kidney Disease | Diovan | Heart | Hydrochlorothiazide | Hypertension | Study | Urology & Nephrology